Katharina Gegenschatz-Schmid, Stefano Buzzi, Jonas Grossmann, Bernd Roschitzki, Riccardo Urbanet, Roman Heuberger, Dorothea Glück, Arik Zucker, Martin Ehrbar Blood-contacting medical implants made of Nitinol and other titanium alloys, such as neurovascular flow diverters and peripheral stents, have the disadvantage of being highly thrombogenic. This makes the use of systemic (dual) anti-platelet / anticoagulant therapies inevitable […]
Qvanteq AG has developed a surface modification – not a coating – that renders titanium alloy-based implants antithrombogenic. Extensive studies have shown that the modified surface suppresses the activation of proteins of the blood coagulation cascade. The technology can be extended from titanium alloys to virtually any material used in medical devices and is therefore […]
Qvanteq, togehter with partners, has developed a process that can render any material, or medical devices made up from a combination of materials, antithrombotic. For inquiries please contact the company.
Qvanteq AG is using MedtechVault for secure communication with its notified body, suppliers and customers. About MedtechVault: MedtechVault is the ideal solution for efficient document and data exchange in the medical device and in-vitro diagnostics industry. MedtechVault enables secure communication between the economic operators like legal manufacturers, [critical] suppliers, authorized representatives, distributors, importers as well […]
Qvanteq AG has developed a fast and simple method to screen materials used for medical devices with respect to their thrombus formation capacity. Respective work is normally done using whole human blood. For inquiries please contact the company.